Photo from Yüksel Ürün/X
May 18, 2024, 10:20
Yüksel Ürün: Top Advances of the Year in Perioperative Therapy for Lung Cancer
Yüksel Ürün shared on X: .
“Top Advances of the Year: Perioperative Therapy for Lung Cancer
- In 2023, perioperative immune checkpoint inhibitors (ICIs) became a game-changer for early-stage non-small cell lung cancer (NSCLC)
- Despite these advances, optimizing patient selection and biomarker use remains a challenge”
Read further.
Source: Yüksel Ürün/X
Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey. His research focuses on genitourinary cancers, covering epidemiology, diagnosis, biomarkers, meta-analysis, and treatment outcomes.
His dedication to patient care and research inspires positive change in the medical field.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 7, 2024, 08:16
Nov 7, 2024, 07:44
Nov 7, 2024, 07:38
Nov 7, 2024, 07:27
Nov 7, 2024, 07:14
Nov 7, 2024, 07:04
Nov 7, 2024, 05:29